BCX-5235

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameBCX-5235
Drug Alias Namethird generation PNP inhibitor (BioCryst)BCX-5235
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionPurine nucleoside phosphorylase inhibitors
TargetsPurine nucleoside phosphorylase
Therapy Area/IndicationsNeoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesBiocryst Pharmaceuticals Inc
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesBiocryst Pharmaceuticals Inc
Active IndicationsN/A
Inactive IndicationsNeoplasms

Other Information

ATC CodeN/A
Related LinksN/A